How should I manage a patient with serum sodium of 115 mEq/L who is neurologically asymptomatic?

Management of Severe Hyponatremia (Na 115 mEq/L) in Neurologically Asymptomatic Patients

Despite the absence of neurological symptoms, a sodium of 115 mEq/L requires active treatment with careful correction, as this level carries mortality risk even without overt symptoms, but you must avoid rapid correction to prevent osmotic demyelination syndrome. 1

Critical Initial Assessment

First, determine if this is truly asymptomatic or if subtle symptoms are present. Even "asymptomatic" patients at this sodium level may have:

• Mild confusion or attention deficits
• Nausea or weakness
• Gait instability

The key mortality data shows that patients with sodium <115 mEq/L who had slower correction (Na 118.8 mEq/L at 48 hours) died, while survivors reached 127.1 mEq/L at 48 hours (P=0.0016). 1 This suggests you cannot simply observe—correction is necessary for survival.

Determine Chronicity and Etiology

Assume chronic hyponatremia unless you have clear evidence of acute onset (<48 hours). 1 This is critical because:

• Chronic hyponatremia should NOT be rapidly corrected due to osmotic demyelination syndrome (ODS) risk 1, 2
• Acute hyponatremia allows faster correction rates

Immediately check:

• Serum and urine osmolality
• Urine sodium
• Volume status (physical exam for hypovolemia, euvolemia, or hypervolemia)
• Rule out thyroid disease, adrenal insufficiency, and medications (especially thiazides) 1

Treatment Algorithm for Asymptomatic/Mildly Symptomatic Na 115 mEq/L

If SIADH (Euvolemic):

Start with fluid restriction to 1L/day combined with increased solute intake 1, 3:

• Monitor sodium Q4-6 hours initially
• Daily weights and strict intake/output
• Add oral salt tablets (NaCl 100 mEq PO TID) if no response 1
• High protein diet to increase solute load

Critical correction limits:

• Maximum 8 mEq/L increase in first 24 hours 1, 2
• Target 4-6 mEq/L increase per day in high-risk patients 4, 5
• Continue until sodium reaches 131 mEq/L 1

If Cerebral Salt Wasting (Hypovolemic):

Do NOT fluid restrict—this increases mortality and stroke risk 1:

• Normal saline infusion at 60-100 mL/hour 1
• Consider fludrocortisone 0.1-0.2 mg daily for 7 days 1
• Monitor sodium Q4 hours
• Same correction limits apply (8 mEq/L per 24 hours maximum)

Critical Pitfalls to Avoid

The Normal Saline Trap

Avoid 0.9% normal saline in SIADH patients—it acts as hypotonic fluid in these patients and can paradoxically worsen hyponatremia or cause dangerous fluctuations 3. The dual effect causes rapid correction during infusion (risking ODS) followed by post-infusion worsening.

Preventing Overcorrection

Inadvertent overcorrection is common and preventable 4, 5:

1. Use desmopressin (DDAVP) prophylactically in high-risk patients to prevent unwanted water diuresis 5, 6, 7
2. If overcorrection occurs (>8 mEq/L in 24 hours):
   • Immediately give D5W intravenously 6, 7
   • Give desmopressin to induce water retention
   • Therapeutic relowering of sodium is safe and recommended 5

Monitoring Requirements

• Sodium levels Q4-6 hours initially 1
• Strict intake/output monitoring
• Daily weights
• Neurological checks every 2-4 hours

When to Escalate Treatment

Only use hypertonic 3% saline if:

• Severe symptoms develop (seizures, altered mental status, coma) 1, 2
• Patient is in subarachnoid hemorrhage setting requiring HHH therapy 1

If hypertonic saline becomes necessary:

• Give 100-150 mL bolus 8
• Target 5-6 mEq/L increase over 6 hours to reverse symptoms 1, 6
• Then immediately slow to achieve total ≤8 mEq/L in 24 hours 1

Second-Line Therapies

If fluid restriction fails in SIADH:

• Urea 40g in 100-150 mL NS every 8 hours (highly effective) 1, 8
• Vaptans (tolvaptan) if available, but risk of overcorrection 2, 8

The evidence strongly supports that at sodium 115 mEq/L, even without overt symptoms, active treatment is necessary for survival, but the approach must be measured and controlled to avoid ODS. The balance is treating aggressively enough to prevent mortality while respecting correction limits to prevent devastating neurological complications.